Alkem Lab Break previous High With good Volume.

Diupdate
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.

Revenue from Operation grew by11.7% YoY during thequarter, with EBITDA margin of 21.7% and Net Profit margin of 18.0%.

Highest Quaterly revinue of 3440 Crore, And highest net profit of 615 crore in sept quater.

Trading ditutup: target tercapai
alkemlabbreakoutChart PatternsTechnical Indicatorsnifty50niftytrendStocksstockstobuystocktradingtradingTrend Analysistrending

Publikasi terkait

Pernyataan Penyangkalan